Evaluation of six months sputum culture conversion as a surrogate endpoint in a multidrug resistant-tuberculosis trial

Janssen funded the C208 Stage II trial and was involved in its design and conduct and in the collection and analysis of the data. All the authors who worked for Janssen at the time of the analysis and manuscript preparation (Paul Meyvisch, Chrispin Kambili, Koen Andries, Myriam Theeuwes, Brian Dannemann, An Vandebosch, Wim Van der Elst) played a role in the decision to publish and preparation of the manuscript.